THE CHEMOTHERAPY OF COLON-CANCER CAN NO LONGER BE IGNORED

被引:90
作者
CUNNINGHAM, D [1 ]
FINDLAY, M [1 ]
机构
[1] ROYAL MARSDEN HOSP, SUTTON SM2 5PT, SURREY, ENGLAND
关键词
D O I
10.1016/0959-8049(93)90036-F
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2077 / 2079
页数:3
相关论文
共 25 条
[1]  
[Anonymous], 1992, Lancet, V339, P1
[2]   ASSOCIATION OF NM23-H1 ALLELIC DELETIONS WITH DISTANT METASTASES IN COLORECTAL-CARCINOMA [J].
COHN, KH ;
WANG, FS ;
DESOTOLAPAIX, F ;
SOLOMON, WB ;
PATTERSON, LG ;
ARNOLD, MR ;
WEIMAR, J ;
FELDMAN, JG ;
LEVY, AT ;
LEONE, A ;
STEEG, PS .
LANCET, 1991, 338 (8769) :722-724
[3]  
DOSE AM, 1993, 7TH P INT C CANC NUR, P95
[4]   RANDOMIZED CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY BY PORTAL-VEIN PERFUSION AFTER CURATIVE RESECTION FOR COLORECTAL ADENOCARCINOMA [J].
FIELDING, LP ;
HITTINGER, R ;
GRACE, RH ;
FRY, JS .
LANCET, 1992, 340 (8818) :502-506
[5]  
FINDLAY M, 1992, P AN M AM SOC CLIN, V11, P170
[6]   THE NONINVASIVE MONITORING OF LOW-DOSE, INFUSIONAL 5-FLUOROURACIL AND ITS MODULATION BY INTERFERON-ALPHA USING IN-VIVO F-19 MAGNETIC-RESONANCE SPECTROSCOPY IN PATIENTS WITH COLORECTAL-CANCER - A PILOT-STUDY [J].
FINDLAY, MPN ;
LEACH, MO ;
CUNNINGHAM, D ;
COLLINS, DJ ;
PAYNE, GS ;
GLAHOLM, J ;
MANSI, JL ;
MCCREADY, VR .
ANNALS OF ONCOLOGY, 1993, 4 (07) :597-602
[7]  
GERSTNER J, 1991, P AN M AM SOC CLIN, V10, P134
[8]   EXPECTANCY OR PRIMARY CHEMOTHERAPY IN PATIENTS WITH ADVANCED ASYMPTOMATIC COLORECTAL-CANCER - A RANDOMIZED TRIAL [J].
GLIMELIUS, B ;
PAHLMAN, L ;
GRAF, W ;
ADAMI, HO ;
TVEIT, K ;
HANSEN, J ;
LILJEGREN, G ;
DOMELoF, L ;
LJUNGQVIST, U ;
BERGMAN, L ;
ENANDER, LK ;
UNDERSKOG, I ;
SoDERBERG, M ;
JoNSSON, PE ;
HAFSTRoM, L ;
HEUMAN, R ;
ATHLIN, L ;
SASSNER, P ;
SELLSTRoM, H .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) :904-911
[9]  
ISACOFF WH, 1993, P AN M AM SOC CLIN, V12, P225
[10]   ACTIVE LIFE EXPECTANCY [J].
KATZ, S ;
BRANCH, LG ;
BRANSON, MH ;
PAPSIDERO, JA ;
BECK, JC ;
GREER, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (20) :1218-1224